About Bionxt
Bionxt is a company based in Vancouver (Canada) founded in 2018.. Bionxt operates in a competitive market with competitors including Impel NeuroPharma, Ensysce, Arecor, Oxular and Souzhou Ribo Life Science, among others.
- Headquarter Vancouver, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bionxt Solutions Inc
-
Annual Revenue
$18.75 K (USD)-92.75as on Dec 31, 2024
-
Net Profit
$-3.69 M (USD)31.22as on Dec 31, 2024
-
EBITDA
$-3.11 M (USD)27.98as on Dec 31, 2024
-
Latest Funding Round
$1.74 M (USD), Post-IPO
Feb 28, 2025
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bionxt
Bionxt is a publicly listed company on the CSE with ticker symbol BNXT in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Bionxt
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $1.7M
-
First Round
First Round
(03 Feb 2020)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Post-IPO - Bionxt | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - Bionxt | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - Bionxt | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Bionxt
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bionxt
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bionxt Comparisons
Competitors of Bionxt
Bionxt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impel NeuroPharma, Ensysce, Arecor, Oxular and Souzhou Ribo Life Science, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Intranasal delivery technology for CNS diseases is developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| domain | founded_year | HQ Location |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| domain | founded_year | HQ Location |
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
|
| domain | founded_year | HQ Location |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| domain | founded_year | HQ Location |
Erythrocyte encapsulation systems for drug delivery are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bionxt
Frequently Asked Questions about Bionxt
When was Bionxt founded?
Bionxt was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Bionxt located?
Bionxt is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Who is the current CEO of Bionxt?
Hugh Rogers is the current CEO of Bionxt.
What is the annual revenue of Bionxt?
Annual revenue of Bionxt is $18.75K as on Dec 31, 2024.
What does Bionxt do?
Bionxt was founded in 2018 in Vancouver, Canada, within the biotechnology sector. Precision transdermal and oral dissolvable drug delivery formulations are developed, alongside rapid screening tests for infectious diseases and oral health. Clinical evaluations of active pharmaceutical ingredients for neurological applications are conducted. Operations center on improving drug accessibility, with Vektor provided as a formulation for efficient delivery of approved neurological medications.
Who are the top competitors of Bionxt?
Bionxt's top competitors include Oxular, PharmaJet and Impel NeuroPharma.
Is Bionxt publicly traded?
Yes, Bionxt is publicly traded on CSE under the ticker symbol BNXT.
What is Bionxt's ticker symbol?
The ticker symbol of Bionxt is BNXT on CSE.